Krystal Biotech, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for KRYS, updated each market day.
KRYS AI Sentiment
AI sees no strong directional signal for Krystal Biotech, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Krystal Biotech, Inc. Common Stock
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Sector
Exchange
Market Cap
$7,604,136,264
Cap Tier
Employees
295
Headquarters
PITTSBURGH, PA
Listed Since
Sept. 20, 2017
Website
KRYS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KRYS Volatility
Krystal Biotech, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
